Clorox Company
Exchange: NYSESector: Consumer DefensiveIndustry: Household & Personal Products
The Clorox Company champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands including Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, Pine-Sol® and now Purell® as well as international brands such as Chux®, Clorinda® and Poett®.
Did you know?
Price sits at 12% of its 52-week range.
Current Price
$101.14
-2.97%GoodMoat Value
$76.93
23.9% overvaluedProfile
Valuation (TTM)
Market Cap$12.34B
P/E16.34
EV$15.91B
P/B38.43
Shares Out121.98M
P/Sales1.83
Revenue$6.76B
EV/EBITDA11.91
Clorox Company (CLX) Stock Analysis
GoodMoat Analysis
Clorox is a household staples company with a strong brand portfolio, but it currently shows weak moat characteristics and trades at a premium to its estimated fair value. The analysis suggests the business may not meet the initial quality gate for a value investor.
Read full analysis
Clorox Company is a leading manufacturer and marketer of consumer and professional cleaning, disinfecting, and household products, including its namesake bleach, Glad bags, and Hidden Valley dressings. Applying the GoodMoat framework, the company's moat appears limited. While it possesses strong brand recognition (criterion 6), it scores poorly on other moat criteria: it lacks network effects, high switching costs, or proprietary data, faces intense competition, and shows no pricing power as evidenced by a -0.8% YoY revenue decline. A moat score below the 5+ threshold suggests a lack of durable competitive advantage. Financially, the high ROE of 235.2% is distorted by a leveraged balance sheet (Debt/Equity of 8.97), and the negative revenue growth is a concern. The Decision Framework's first step is a 'Moat & Quality Gate.' With a likely low moat score and negative growth, the business profile is unfavourable for proceeding to detailed valuation. Even if one proceeded, the current price of $104.76 is significantly above the GoodMoat Target of $76.93, indicating a negative margin of safety and an overvalued position. For a value investor, Clorox presents a case where a premium price is being paid for a business with questionable competitive strength and stagnant growth, failing the framework's initial screens.
Market Cap$12.34B
Current Price$101.14
P/E Ratio16.34
Forward P/E—
PEG Ratio-0.97
EPS$6.52
Book Value$2.63
P/B Ratio38.43
CLX Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use -0.5% FCF growth (CAGR)
Cash vs Debt
Net Debt: 2.7B
Revenue
6.2B
FY19
6.7B
FY20
7.3B
FY21
7.1B
FY22
7.4B
FY23
7.1B
FY24
7.1B
FY25
Net Income
820M
FY19
939M
FY20
710M
FY21
462M
FY22
149M
FY23
280M
FY24
810M
FY25
CLX 52-Week Range
$96.33
$137.84
50-Day MA: $114.65200-Day MA: $113.69
Did you know?
Trading 24% above its estimated fair value of $76.93.
Clorox Company (CLX) Financial Summary
Clorox Company (CLX) is a Consumer Defensive company in the Household & Personal Products industry, listed on NYSE. The stock currently trades at $101.14 with a market capitalization of $12.34B.
Key valuation metrics include a P/E ratio of 16.34, price-to-book ratio of 38.43, and EPS of $6.52. The company reports a profit margin of 11.2% and return on equity of 235.2%.
CLX Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $12.34B |
| P/E Ratio | 16.34 |
| EPS | $6.52 |
| P/B Ratio | 38.43 |
| P/S Ratio | 1.83 |
| EV/EBITDA | 11.91 |
| Dividend Yield | 4.88% |
| Profit Margin | 11.2% |
| Return on Equity | 235.2% |
| Debt/Equity | 8.97 |
CLX Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $6.21B | $820.00M |
| FY20 | $6.72B | $939.00M |
| FY21 | $7.34B | $710.00M |
| FY22 | $7.11B | $462.00M |
| FY23 | $7.39B | $149.00M |
| FY24 | $7.09B | $280.00M |
| FY25 | $7.10B | $810.00M |
Clorox Company (CLX) Valuation
Based on GoodMoat's DCF model, Clorox Company has a fair value estimate of $76.93. At the current price of $101.14, the stock appears 31.5% overvalued relative to our intrinsic value estimate.
CLX Quality Indicators
Clorox Company maintains a profit margin of 11.2% and an operating margin of 18.1%. Return on equity stands at 235.2%. The current ratio is 0.84. Debt-to-equity ratio is 8.97.
About Clorox Company
The Clorox Company champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands including Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, Pine-Sol® and now Purell® as well as international brands such as Chux®, Clorinda® and Poett®.
CLX Free Cash Flow
Clorox Company generated $761.00M in trailing twelve-month free cash flow, representing an FCF yield of 6.17%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
CLX Shares Outstanding
Clorox Company has 0.12 billion shares outstanding at a share price of $101.14, giving it a market capitalization of $12.34B.